Sumitomo Mitsui Trust Asset Management Cuts Stake in Healthcare & Medical Investment Corporation (3455) to 7.56% | Large Shareholding Report

A large shareholding report (EDINET filing) reveals that Sumitomo Mitsui Trust Asset Management has reduced its stake in Healthcare & Medical Investment Corporation (3455) to 7.56%. The asset management arm of Sumitomo Mitsui Trust Group has executed this divestment. Healthcare & Medical Investment Corporation is a J-REIT that acquires and operates healthcare-related real estate including medical and nursing facilities to generate stable rental income. At the filing date stock price of 97,600 yen, the company's market capitalization reflects a significant position, with the 7.56% stake representing a major shareholder's holdings.

Phased Reduction of 4.89 Points Over One Year

Sumitomo Mitsui Trust Asset Management initially disclosed a 12.45% stake on September 5, 2025. By August 28, 2026, this position had declined to 7.56%, representing a 4.89-point reduction over twelve months. The company submitted six disclosure filings during this period, indicating a deliberate, multi-stage approach to unwinding its position. The estimated proceeds from this sale reached ¥360 million, demonstrating the substantial scale of this portfolio adjustment rather than a minor transaction.

Portfolio Focused on J-REIT Investments

Among the 274 securities in which this firm holds over 5%, the top five holdings reveal a clear pattern. Peace Real Estate Investment Corporation accounts for 15.87%, Hulic Reit for 13.41%, CRE Logistics Fund for 10.38%, NTT Urban Development Reit for 9.36%, and Japan Prime Realty Investment Corporation for 8.54%. All of these are J-REITs, demonstrating the asset manager's concentrated strategy in real estate investment trusts. Healthcare & Medical Investment Corporation represents one component within this broader institutional investment activity in the sector, suggesting the current sale reflects overall portfolio rebalancing rather than a sector exit.

Limited Competition in the Shareholder Base

Among other investors disclosing holdings in Healthcare & Medical Investment Corporation, Nomura Securities reports a 0.49% stake. Sumitomo Mitsui Trust Asset Management's 7.56% position maintains substantial distance from competitors. Consequently, this sale does not trigger significant restructuring of the company's shareholder composition, with the lead investor status remaining intact.

*Speculation: The firm may be rebalancing its portfolio among J-REIT holdings while monitoring longer-term demand prospects for healthcare-related real estate amid Japan's aging demographic trends.